HOUSE BILL REPORT
HJM 4004
As Passed House:
March 8, 1999
Brief Description: Urging support of prostate cancer research.
Sponsors: Representatives Dickerson, Cody, Skinner, O'Brien, Veloria, Kessler, McIntire, Wood, Lovick, Romero, Conway, Ruderman, Hurst and Kenney.
Brief History:
Committee Activity:
Health Care: 1/28/99, 2/9/99 [DP].
Floor Activity:
Passed House: 3/8/99, 97-0.
|
Brief Summary of Bill
$Prostate cancer is a serious disease among men.
$The federal government is asked to allocate more funding for prostate cancer research.
|
HOUSE COMMITTEE ON HEALTH CARE
Majority Report: Do pass. Signed by 12 members: Representatives Cody, Democratic Co-Chair; Parlette, Republican Co-Chair; Pflug, Republican Vice Chair; Schual-Berke, Democratic Vice Chair; Alexander; Boldt; Campbell; Conway; Edmonds; Edwards; Mulliken and Ruderman.
Staff: Bill Hagens (786-7131).
Background: Based on national cancer research: Prostate cancer is one of the most common cancers of American men; it is estimated that in 1999, about 179,300 new cases of prostate cancer will be diagnosed in the United States; prostate cancer is the second leading cause of cancer death in men, exceeded only by lung cancer; 37,000 men in the United States are projected to die of this disease during 1999; and African-American men have the highest incidence of prostate cancer of any population of men in the world today.
Summary of Bill:
President Clinton and Congress are asked to support increased federal funding for prostate cancer research.
Appropriation: None.
Fiscal Note: Not requested.
Testimony For: Prostate cancer is a major threat to men's health. More money should be spent on prostate cancer research.
Testimony Against: None.
Testified: Representative Dickerson, prime sponsor; Karen McDonell, Public Advocate; Frank Kirk and Pearline Dottin, American Cancer Society; and Paul Sanders, Puget Sound American Cancer Society Task Force on Prostate Cancer.